• ELPUB_slider



Our (e)Books and (e)Journals

IOS Press serves the information needs of scientific and medical communities worldwide. See what's new and browse our books and journals to learn more.

  • kudos_static_310_x_62
  • Slider Journal Catalogue 2016
  • go-to-ejournals
  • Go to IOS Press Ebooks
  • Millpress and Delft University Press imprints IOS Press
  • Statement side banner
  • worldofstatisticsbanner



New Method to Grow and Transplant Muscle Stem Cells Holds Promise for Treatment of Muscular Dystrophy

June 28, 2016 - Satellite cells are stem cells found in skeletal muscles. While transplantation of such muscle stem cells can be a potent therapy for degenerative muscle diseases such as Duchenne muscular dystrophy, these cells tend to lose their transplantation efficiency when cultured in vitro. In a study in the current issue of the Journal of Neuromuscular Diseases, researchers treated these stem cells with leukemia inhibitory factor (LIF), which effectively maintained the undifferentiated state of the satellite cells and enhanced their transplantation efficiency.

June 28, 2016

IOS Press Impact Factors Continue to Rise

June 23, 2016 - IOS Press has announced that its journal Impact Factors continue to increase, according to the 2015 Journal Citation Reports® (JCR) released by Thomson Reuters © 2016.

June 23, 2016

Semantic Web journal gets its first Impact Factor

June 21, 2016 - The first Impact Factor for our Semantic Web journal has been released by Thomson Reuters.

June 21, 2016

Neurocentria Publishes Peer-Reviewed Paper Showing Mechanism of Action for Its Drug that Reverses Cognitive Impairment in Humans

June 14, 2016 - Neurocentria, Inc. announced today the publication of a scientific paper showing how its candidate drug, L­-Threonic acid Magnesium salt (L-TAMS), reverses cognitive impairment in humans, as previously demonstrated. The paper titled "Regulation of structural and functional synapse density by L-threonate through modulation of intraneuronal magnesium concentration" was published in the medical journal Neuropharmacology. The drug's discovery is based on more than a decade of research at Stanford, Tsinghua University, and MIT.

June 14, 2016